Ahrens Investment Partners’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | $79.5K | Buy |
+1,900
| New | +$79.5K | 0.04% | 252 |
|
2022
Q3 | – | Sell |
-19,850
| Closed | -$842K | – | 247 |
|
2022
Q2 | $842K | Buy |
19,850
+8,650
| +77% | +$367K | 0.37% | 61 |
|
2022
Q1 | $510K | Sell |
11,200
-18,700
| -63% | -$852K | 0.16% | 100 |
|
2021
Q4 | $1.45M | Sell |
29,900
-11,925
| -29% | -$578K | 0.64% | 34 |
|
2021
Q3 | $1.99M | Sell |
41,825
-2,550
| -6% | -$122K | 0.95% | 27 |
|
2021
Q2 | $2.15M | Sell |
44,375
-2,050
| -4% | -$99.4K | 0.99% | 17 |
|
2021
Q1 | $2.15M | Sell |
46,425
-28,400
| -38% | -$1.31M | 1.08% | 20 |
|
2020
Q4 | $3.56M | Buy |
74,825
+54,175
| +262% | +$2.58M | 1.91% | 11 |
|
2020
Q3 | $885K | Buy |
20,650
+300
| +1% | +$12.9K | 0.59% | 44 |
|
2020
Q2 | $830K | Buy |
+20,350
| New | +$830K | 0.51% | 50 |
|